Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

Heparin-Releasable Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (Tfpi) is Increased in the Coronary Circulation After Coronary Spasm in Patients with Coronary Spastic Angina - Evidence for association with and regulation by LDL in human plasma

By Nishiyama K.   Ogawa H.   Yasue H.   Soejima H.   Misumi K.   Kugiyama K.   Tsuji I.   Kumeda K.  

Thrombosis Research, Vol. 89, Iss. 3, 1998-02 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite

Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid

By Thyzel E.   Siegling S.   Gotting C.   Tinneberg H.-R.   Brinkmann T.   Kleesiek K.  

Thrombosis Research, Vol. 109, Iss. 5, 2003-03 ,pp. : 329-332

Elsevier

Access to resources Recommend Favorite

Tryptase inhibits motility of human spermatozoa mainly by activation of the mitogen-activated protein kinase pathway

By Weidinger S.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 456-461

Oxford University Press

Access to resources Recommend Favorite

A Kinetic Analysis of the Interaction of Human Recombinant Tissue Factor Pathway Inhibitor with Factor Xa Utilizing an Immunoassay and the Effect of Antithrombin III/Heparin on the Complex Formation - one N- and two O-linked carbohydrate chains are located between Kunitz domains 2 and 3 and one N-linked carbohydrate chain is in Kunitz domain 2

By Kamikubo Y.-i.   Hamuro T.   Takemoto S.   Nakahara Y.   Kamei S.   Nakagaki T.   Miyamoto S.   Funatsu A.   Kato H.  

Thrombosis Research, Vol. 89, Iss. 4, 1998-02 ,pp. : 179-186

Elsevier

Access to resources Recommend Favorite